X4 Pharmaceuticals (XFOR) Tops Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts XFOR Hot Sheet
Join SI Premium – FREE
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.01), $0.14 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts X4 Pharmaceuticals (XFOR) at Overweight
- Stifel says AI infrastructure remains supply-gated into earnings
- Ategrity reports record Q2 results, names new CFO
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
